What role does Metformin play in reducing or influencing inflammatory markers in systemic conditions and how might this contribute to its broader health benefits?
Gaurav ChauhanContributor
Sign Up to our social questions and Answers Engine to ask questions, answer peopleβs questions, and connect with other people.
Please briefly explain why you feel this question should be reported.
Please briefly explain why you feel this answer should be reported.
Please briefly explain why you feel this user should be reported.
Metformin reduces inflammatory markers like CRP and IL-6, potentially lowering chronic inflammation and risk of diseases like type 2 diabetes and cardiovascular disorders.
Metformin reduces inflammation by inhibiting the NF-kB pathway, which may lower risk of chronic diseases like type 2 diabetes and cardiovascular ailments.